Dermatologic Agents Concept

Vocabulary Service

MeSH

Overview

subject area of

2016 Addendum to the Canadian Guidelines for the Management of Plaque Psoriasis 2009 Journal Articles
A Consensus on Acne Management Focused on Specific Patient Features Journal Articles
A systematic review of recent randomized controlled trials for palmoplantar pustulosis. Journal Articles
A treatment for severe nodular acne: a randomized investigator-blinded, controlled, noninferiority trial comparing fixed-dose adapalene/benzoyl peroxide plus doxycycline vs. oral isotretinoin Journal Articles
Adapalene 0.1% lotion in the treatment of acne vulgaris: results from two placebo-controlled, multicenter, randomized double-blind, clinical studies. Journal Articles
Age affects drug survival rates of interleukin (IL)‐17 and IL‐23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi‐country, cohort study Journal Articles
Are Excipients Really Inert Ingredients? A Review of Adverse Reactions to Excipients in Oral Dermatologic Medications in Canada Journal Articles
Biologic survival. Journal Articles
Biosimilars for psoriasis: worldwide overview of regulatory guidelines, uptake and implications for dermatology clinical practice Journal Articles
Brodalumab success in patients with moderate-to-severe psoriasis who failed previous interleukin-17A inhibitors Journal Articles
Canadian Patients’ Preferences in Topical Psoriasis Care: Insights From the PROPEL Surveys Journal Articles
Clinical Significance of Markedly Elevated Serum Creatine Kinase Levels in Patients with Acne on Isotretinoin Journal Articles
Effect of Quality of Life Impact and Clinical Severity on Adherence to Topical Acne Treatment Journal Articles
Effect of secukinumab on quality of life and psoriasis-related symptoms: A comparative analysis versus ustekinumab from the CLEAR 52-week study Journal Articles
Effect of tofacitinib withdrawal and re‐treatment on patient‐reported outcomes: results from a Phase 3 study in patients with moderate to severe chronic plaque psoriasis Journal Articles
Efficacy Outcomes in Patients Using Alefacept in the AWARE Study Journal Articles
Enduring sexual dysfunction after treatment with antidepressants, 5α-reductase inhibitors and isotretinoin: 300 cases Journal Articles
Granulocyte–macrophage colony‐stimulating factor ( GM ‐ CSF ) as a therapeutic target in psoriasis: randomized, controlled investigation using namilumab, a specific human anti‐ GM ‐ CSF monoclonal antibody Journal Articles
Hypertrophic scarring: the greatest unmet challenge after burn injury Journal Articles
Immune Thrombocytopenia Associated with Efalizumab Therapy for Psoriasis Journal Articles
Immunotherapies in Dermatologic Disorders Journal Articles
Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report. Journal Articles
Integrated safety analysis of treatment‐emergent eczematous reactions in patients with moderate‐to‐severe psoriasis treated with ixekizumab, etanercept and ustekinumab Journal Articles
Ixekizumab improves patient-reported outcomes in patients with active psoriatic arthritis and inadequate response to tumour necrosis factor inhibitors: SPIRIT-P2 results to 52 weeks. Journal Articles
Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials. Journal Articles
Management of Guttate Psoriasis: A Systematic Review Journal Articles
Morphea in patients with psoriasis treated with ustekinumab: a scoping review Journal Articles
Newer approaches in topical combination therapy for acne. Journal Articles
Non-Traumatic Sixth Nerve Palsy in a Young Patient Journal Articles
Novel Management of Isotretinoin-Induced Hypertriglyceridemia in an Adolescent With Severe Acne Journal Articles
Occurrence of pregnancy and pregnancy outcomes during isotretinoin therapy Journal Articles
Off-Label High-Dose Secukinumab for the Treatment of Moderate-to-Severe Psoriasis Journal Articles
Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial Journal Articles
Practical Understanding of Mean Percent Psoriasis Area and Severity Index Reduction for Biologics Journal Articles
Protection afforded by controlled application of a barrier cream: a study in a workplace setting Journal Articles
Psoriasis patients’ preference for an aerosol foam topical formulation Journal Articles
Rosacea: update on management and emerging therapies. Journal Articles
Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE) Journal Articles
Secukinumab demonstrates sustained efficacy in clearing skin and improving patient-reported outcomes in patients with moderate-to-severe psoriasis through 2 years of treatment: Results from the CLEAR study Journal Articles
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study Journal Articles
Systemic Immunomodulatory Treatments for Patients With Atopic Dermatitis Journal Articles
Topical benzoyl peroxide for acne Journal Articles
Topical calcipotriol in childhood psoriasis Journal Articles
Topical treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials Journal Articles
Use of Calcipotriene Cream (Dovonex?? Cream) Following Acute Treatment of Psoriasis Vulgaris with the Calcipotriene/Betamethasone Dipropionate Two-Compound Product (Taclonex??) Journal Articles
Ustekinumab does not increase risk of new or recurrent cancer in inflammatory bowel disease patients with prior malignancy Journal Articles
VERRUCAE PLANAE OF THE FACE Journal Articles
When Is Recalcitrant Pyoderma Gangrenosum Truly Recalcitrant? Journal Articles
When is Recalcitrant Pyoderma Gangrenosum Truly Recalcitrant? Journal Articles